# Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years

> **NCT02757963** · PHASE4 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1679 (actual)

## Conditions studied

- Prostatic Hyperplasia

## Interventions

- **OTHER:** Benign prostatic enlargement (BPE)/Benign prostatic obstruction (BPO) screening tool
- **OTHER:** International Prostate Symptom Score (IPSS) screening tool

## Key facts

- **NCT ID:** NCT02757963
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-12
- **Primary completion:** 2017-02-27
- **Final completion:** 2017-02-27
- **Target enrollment:** 1679 (ACTUAL)
- **Last updated:** 2021-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02757963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02757963, "Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02757963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*